¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"thermal enhancement ratio"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • air pollution ratio
    ´ë±â¿À¿°·ü
  • albumin CSF/serum ratio
    ¾ËºÎ¹Î³úô¼ö¾×/Ç÷ûºñ
  • albumin-globulin ratio
    ¾ËºÎ¹Î±Û·ÎºÒ¸°ºñ
  • birth-death ratio
    Ãâ»ý»ç¸Áºñ
  • blood urea nitrogen/creatinine ratio
    Ç÷¾×¿ä¼ÒÁú¼Ò/Å©·¹¾ÆÆ¼´Ñºñ
  • body-weight ratio
    üÁß½ÅÀåºñ
  • breathing reserve ratio
    ȯ±â¿¹ºñºñ
  • common ratio
    °øºñ
  • contrast to noise ratio
    ´ëÁ¶´ëÀâÀ½ºñ
  • correlation ratio
    »ó°üºñ
  • cumulative incidence ratio
    ´©Àû¹ß»ýºñ
  • cup-disc ratio
    À¯µÎÇÔ¸ôºñ
  • cardiothoracic ratio
    ½ÉÀå°¡½¿ºñ, ½ÉÈäºñ
  • cell color ratio
    ÀûÇ÷±¸»ö¼Òºñ
  • caliber ratio
    1. Ç÷°ü°æºñÀ² 2. ±¸°æºñÀ²
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • periventricular enhancement
    ³ú½ÇÁÖÀ§Á¶¿µÁõ°­
  • rim enhancement
    Å×Áõ°­
  • ring enhancement
    °í¸®Á¶¿µÁõ°­
  • thermal biofeedback
    ¿­¹ÙÀÌ¿ÀÇǵå¹é, ¿­»ýüµÇ¸ÔÀÓ
  • thermal burn
    ¿­È­»ó
  • thermal capacity
    ¿­¿ë·®
  • thermal coagulation
    ¿­ÀÀ°í
  • thermal conductivity
    ¿­ÀüµµÀ²
  • thermal contraction
    ¿­¼öÃà
  • thermal death
    ¿­»ç, ¿­»ç¸ê
  • thermal diffusibility
    ¿­È®»êÀ²
  • radio-frequency thermal effect
    °íÁÖÆÄ¿­È¿°ú
  • thermal efficiency
    ¿­È¿À²
  • thermal energy
    ¿­¿¡³ÊÁö
  • thermal disc oxygenator
    ¿­¿ø¹Ý»ê¼Ò°ø±Þ±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • rapid acquisition with relaxation enhancement (RARE)
    ±Þ¼Ó ȹµæ ÀÌ¿Ï Áõ°­
  • DeRitis ratio
    µå¸®Æ¼½ººñÀ²
  • Donnan ratio
    µ·³­À²
  • G/N ratio
    G/Nºñ Æ÷µµ´ç°ú Áú¼ÒÀÇ ºñÀ² .
  • INR => International Normalized Ratio
    ±¹Á¦Á¤»óÈ­ºñÀ²
  • International Normalized Ratio
    ±¹Á¦Á¤»óÈ­ºñÀ²
  • International Normalized Ratio=INR
    ±¹Á¦Á¤»óÈ­ºñ
  • L/S ratio
    L/S ºñÀ²
  • S-D ratio
    ¼öÃà±â-À̿ϱ⠺ñ (â¥õêÑ¢-ì¬èÐÑ¢ Ýï)
  • SNR (signal to noise ratio)
    ½ÅÈ£´ë ÀâÀ½ºñÀ²
  • V/Q => ventilation/perfusion ratio
    ȯ±â/°ü·ùºñ
  • VA/Q => ventilation/perfusion ratio
    ȯ±â/°ü·ù ºñ
  • air entrainment ratio
    °ø±âÀ¯ÀÔ·ü.
  • air pollution ratio
    ´ë±â¿À¿°·ü(ÊÙËô).
  • albumin CSF/serum ratio
    ¾ËºÎ¹Î ³úô¼ö¾×/Ç÷û ºñ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • immunological enhancement
    ¸é¿ªÁõ°­.
  • immunological enhancement
    ¸é¿ªÁõ°­.
  • inflow enhancement
    À¯ÀÔ Áõ°­
  • minimal enhancement
    ¹Ì¹ÌÇÑ Á¶¿µÁõ°­, °æµµÀÇ Á¶¿µÁõ°­
  • paradoxical enhancement
    ¿ª¼³Àû Á¶¿µÁõ°­
  • paramagnetic proton relaxation enhancement
    »óÀÚ¼º ¾çÀÚ ÀÌ¿Ï Áõ°­
  • peripheral linear enhancement
    ¸»ÃÊ ¼±Çü Á¶¿µÁõ°­
  • peripheral rim enhancement
    Å׵θ® Á¶¿µÁõ°­
  • postanodal enhancement
    ¾ç±ØÈÄÁõ°­.
  • postanodal enhancement
    ¾ç±ØÈÄÁõ°­(åÕпý­ñòË­)
  • posterior echo enhancement
    ÈÄ¹æ ¿¡ÄÚ Áõ°­, ÈÄ¹æ ¸Þ¾Æ¸®Áõ°­
  • posterior echo enhancement
    ÈĹæ (ý­Û°) ¿¡ÄÚ Áõ°­ (ñòË­), ÈĹæ (ý­Û°) ¸Þ¾Æ¸® ?
  • proton relaxation enhancement
    ¾çÀÚ ÀÌ¿Ï Áõ°­
  • rapid acquisition with relaxation enhancement (RARE)
    ±Þ¼Ó ȹµæ ÀÌ¿Ï Áõ°­
  • rim enhancement
    Å׵θ® Á¶¿µÁõ°­
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • thermal polymer
    ¿­ ÁßÇÕü (æðñìùêô÷)
  • thermal quenching
    ¼Ò¿­ (á¼æð)
  • thermal reactivation
    ¿­ ÀçºÎȰ (æðî¢Ý·üÀ)
  • absorption ratio
    Èí¼öÀ² (ýåâ¥ëÒ)
  • acceptor-control ratio
    ¼ö¿ëü Á¦¾îÀ² (â¥é»ô÷ ð¤åÙëÒ)
  • affinity ratio
    ģȭºñ(öÑûúÝï)
  • A/G ratio
    A/G ºñ (Ýï)
  • albumin/globulin ratio
    ¾ËºÎ¹Î/±Û·ÎºÒ¸° ºñ(Ýï)
  • asymmetry ratio
    ºÒ±Õµîºñ (ÝÕгÔõÝï)
  • A+T/G+C ratio
    A+T/G+C ºñ (Ýï)
  • base-pair ratio
    ¿°±â¦ ºñ(Ýï)
  • base ratio
    ¿°±âºñ(ç¤ÐñÝï)
  • channels ratio method
    ä³Î ºñÀ²¹ý(Ýï×ËÛö)
  • coding ratio
    ºÎÈ£ºñ(ݬûÜÝï)
  • dichroic ratio
    ÀÌ»öºñ(ì£ßäÝï)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • velocity ratio
    ¼Óµµºñ
  • acoustic enhancement
    À½ÇâÁõ°­
  • CE [=contrast enhancement]
    Á¶¿µÁõ°­
  • contrast enhancement [=CE]
    Á¶¿µÁõ°­
  • contrast enhancement scan
    Á¶¿µÁõ°­½ºÄµ
  • dense enhancement
    °­ÇÑ Á¶¿µÁõ°­
  • edge enhancement
    º¯¿¬Áõ°­
  • enhancement
    Áõ°­
  • flow related enhancement
    À¯µ¿°ü·ÃÁõ°­
  • gradient echo technique magnetic susceptibility proton relaxation enhancement
    °æ»ç¿¡ÄÚ¹ý±âÈ­À²¼ºÀÚÀÌ¿ÏÁõ°­
  • inflow enhancement
    À¯ÀÔÁõ°­
  • minimal enhancement
    ¹Ì¹ÌÇÑÁ¶¿µÁõ°­, °æµµÀÇÁ¶¿µÁõ°­
  • paradoxical enhancement
    ¿ª¼³ÀûÁ¶¿µÁõ°­
  • paramagnetic proton relaxation enhancement
    »óÀÚ¼º¾çÀÚÀÌ¿ÏÁõ°­
  • peripheral linear enhancement
    ¸»Ãʼ±ÇüÁ¶¿µÁõ°­
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
L/S lactase/sucrase [ratio]; lecithin/ sphingomyelin [ratio]; lipid/saccharide [ratio]; longitudinal sec...
ADE acute disseminated encephalitis; adverse drug event; antibody-dependent enhancement; apparent digest...
DEPT distortionless enhancement by polarization transfer
FRE Fischer rat embryo; flow-related enhancement
LME left mediolateral episiotomy; leukocyte migration enhancement
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
TEA Thermal Energy Analyzer
TIMS Thermal ionization mass spectometry
L/S ratio Lecithin/sphingomyelin ratio
ADE Antibody-dependent enhancement
CE Contrast enhancement
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • linear coefficient of thermal expansion
    ¼± ¿­ ÆØÃ¢ °è¼ö
  • noxious thermal stimulus
    À¯ÇØ ¿­ ÀÚ±Ø
  • radio-frequency thermal effect
    °íÁÖÆÄ ¿­ È¿°ú
  • thermal
    ¿­¼º, ¿­ÀÇ, ¿­¼ºÀÇ
    ¿­¿¡ °üÇÑ. ¿­ÀÌ Æ¯Â¡ÀÎ.
  • thermal analysis
    ¿­ ºÐ¼®
  • thermal camera
    ¿­ Ä«¸Þ¶ó
  • thermal camera time response
    ¿­ Ä«¸Þ¶ó ½Ã°£ ¹ÝÀÀ
  • thermal coagulation
    ¿­ ÀÀ°í
  • thermal contraction
    ¿­ ¼öÃà
  • thermal damage mechanisms
    ¿­ ¼Õ»ó ±âÀü
  • thermal diffusion
    ¿­ È®»ê
    È¥ÇÕ À¯Ã¼ÀÇ ³»ºÎ¿¡ ¿Âµµ ±¸¹è°¡ ÀÖÀ» ¶§ ¼ººÐ¿¡ µû¶ó °¢°¢ °í¿Â Ãø°ú Àú¿Â ÃøÀ¸·Î ¸ð¿© ºÐ¸®µÇ´Â Çö»ó.
  • thermal efficiency
    ¿­ È¿À²
    ¿­ ±â°ü¿¡ ÀÇÇØ ¿­ ¿¡³ÊÁö¸¦ ÀÏ·Î º¯È¯ÇÒ ¶§ ¾ò¾îÁø Àϰú ÁÖ¾îÁø ¿­ ¿¡³ÊÁö¿ÍÀÇ ºñ.
  • thermal energy
    ¿­ ¿¡³ÊÁö
  • thermal expansion
    ¿­ ÆØÃ¢
    ÁÖÁ¶ ½Ã °¡¿­·Î »ý±â´Â ¸Å¸ôÀçÀÇ ÆØÃ¢. ÀÏÁ¤ÇÑ ¾Ð·Â ¾Æ·¡ ¿Âµµ°¡ ³ô¾ÆÁü¿¡ µû¶ó ¹°Ã¼°¡ ÆØÃ¢ÇÏ´Â °ÍÀ» ¿­ ÆØÃ¢À̶ó ÇÑ´Ù. ÀÌ·¯ÇÑ ¿­ ÆØÃ¢ÀÌ ÁÖÁ¶ ½Ã¿¡ ±Ý¼Ó ÇÕ±ÝÀÇ ¼öÃàÀ» º¸»óÇÏ´Â Á¤µµ·Î ¸Å¸ôÀç¿¡ ÁÖ¾îÁ®¾ß ÇÑ´Ù.
  • thermal information
    ¿­ Á¤º¸
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
thermal barrier <radiobiology> In magnetic mirror devices, this is a depression of electrostatic potential formed by enhancing ion loss in the region between the central cell and the positive potential plug. The thermal barrier significantly reduces the density requirements in the plug and lowers the overall power required to sustain the solenoidal plugging by thermally decoupling central cell electrons from the end plugs.
(09 Oct 1997)
thermal burn A burn caused by heat.
(05 Mar 2000)
thermal capacity <chemistry> The amount of energy required to raise the temperature of an object by one degree Celsius (or Kelvin), it is represented by the symbol C and is given in units of J/K.
(09 Jan 1998)
thermal conductivity <radiobiology> Degree to which a substance transmits heat. (basic definition, I believe, is: (heat flow) = (thermal conductivity) (temperature gradient))
(09 Oct 1997)
thermal conversion cycle <radiobiology> Process of generating electrical power with a fusion reactor by means of a steam / other gas turbine. This is distinct from direct conversion cycles.
(09 Oct 1997)
thermal cover Vegetative condition, generally with greater than 70% canopy closure and 40 feet in height, that can significantly ameliorate weather effects such as wind, heat, cold, and snow. Used by wildlife in winter.
(05 Dec 1998)
thermal efficiency <radiobiology> Ratio of the electric power produced by a power plant to the original amount of heat produced. This measures the efficiency with which the thermal energy is converted to electricity.
(09 Oct 1997)
thermal expansion <radiobiology> Characteristic property of most solids and liquids which causes their volume to increase when they are heated. Thermal expansion and contraction can cause structural problems in pulsed fusion devices.
(09 Oct 1997)
thermal melting profile In general a record of the phase state of a system over a temperature range. Phase changes can be detected by exothermy or endothermy. Valuable in studying lipid and DNA structures.
(18 Nov 1997)
thermal neutron <radiobiology> A neutron in thermal equilibrium with its surrounding environment. Thermal neutrons are those that have been slowed down by a moderator to speeds characteristic of the local temperature.
Compare: fast neutron.
(09 Oct 1997)
thermal resource A facility that produces electricity by using a heat engine to power an electric generator. The heat may be supplied by the combustion of coal, oil, natural gas, biomass, or other fuels, including nuclear fission, solar, or geothermal resources.
(05 Dec 1998)
thermal sense The ability to distinguish differences of temperature.
Synonym: temperature sense, thermal sense, thermic sense, thermesthesia.
Origin: thermo-+ G. Aisthesis, sensation
(05 Mar 2000)
thermal sensors Sensors that detect tiny changes in heat or temperature.
(14 Nov 1997)
thermal spectrum The part of the invisible spectrum of wave length just longer than that of visible red light.
Synonym: thermal spectrum.
(05 Mar 2000)
thermal velocity <radiobiology> Average speed (magnitude of velocity) of a particle at a given temperature (in a Maxwellian velocity distribution).
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inverse ratio
    (¼ö)¹Ýºñ;¿ªºñ
  • mass ratio
    Áú·®ºñ (ÃßÁøºÎ¸¦ Á¦¿ÜÇÑ ·ÎÄÏ º»Ã¼¿¡ ´ëÇÑ ÃÑÁß·®ÀÇ ºñÀ²,ÃßÁø¾à ÃæÀüÀ²)
  • payout ratio
    ¹è´ç ¼ºÇâ
  • priceearnings ratio
    ÁÖ°¡ ¼öÀÍ·ü 9
  • ratio
    ºñ;ºñÀ²
  • respiratory quotient (ratio)
    È£Èí·ü;È£Èíºñ(³»¹ñ´Â ź»ê°¡½ºÀÇ ¾ç°ú ¿ÜºÎ·ÎºÎÅÍ Èí¼öÇÏ´Â »ê¼Ò·®°úÀÇ ºñ)
  • risk-benefit ratio
    À§Ç輺°ú ¼öÀͼº°úÀÇ ºñÀ²
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á